MUCL1 in triple-negative breast cancer: a novel marker associated with the luminal androgen receptor subtype

Franz-Leonard Klaus, Isabella Kitzke, Evelyn Klein, Carolin Mogler, Alexander Muckenhuber · 2026

Read MUCL1 in triple-negative breast cancer: a novel marker associated with the luminal androgen receptor subtype by Franz-Leonard Klaus, Isabella Kitzke, Evelyn Klein, Carolin Mogler, Alexander Muckenhuber (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13088539.txt.

Description

A peer-reviewed research article from Europe PMC (2026). Triple-negative breast cancer (TNBC) comprises several molecularly distinct subtypes. The luminal androgen receptor (LAR) subtype is characterized by AR expression, displays luminal-like gene signatures, and often co-expresses FOXA1 and GCDFP-15, but its immunohistochemical identification remains challenging. Through transcriptomic analyses of GEO datasets, we identified MUCL1 as a candidate marker and validated its protein expression in a retrospective cohort of 106 TNBCs.

Catalog record

CREATORFranz-Leonard Klaus, Isabella Kitzke, Evelyn Klein, Carolin Mogler, Alexander Muckenhuber
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13088539

Browse the full library · About the Tower of Babel